Preparation and Physicochemical Characterization of Amoxicillin β-cyclodextrin Complexes

被引:0
作者
Catherine Bisson-Boutelliez
Stephane Fontanay
Chantal Finance
Francine Kedzierewicz
机构
[1] Nancy-University,SRSMC
[2] CNRS,undefined
[3] Faculté de Pharmacie,undefined
来源
AAPS PharmSciTech | 2010年 / 11卷
关键词
amoxicillin; complex; β-cyclodextrin; DSC-TG-SM; FT-IR; HPLC stability constant; NMR;
D O I
暂无
中图分类号
学科分类号
摘要
Amoxicillin (AMOX), a penicillin A, belongs to the β-lactam family It is usually the drug of choice within the class because it is better absorbed, following oral administration, than other β-lactam antibiotics. Its β-lactamase degradation might be prevented by using a molecular [AMOX:β-CD] complex. The aim of this work was to prepare complexes using two methods and then characterize interactions between AMOX and the native β-CD. The extent of complexation in solution has been evaluated by high-performance liquid chromatography (HPLC), nuclear magnetic resonance (NMR), and 2D rotating-frame Overhauser enhancement spectroscopy (2D ROESY). Mass changes (TG), calorimetric effects (DSC), and mass spectrometry (MS) were determined on the same sample under identical conditions using the Skimmer coupling system. Skimmer and infrared spectroscopy (FT-IR) were used to characterize the solid state of the binary system. Complexation of AMOX with β-CD was proven by FT-IR, NMR, DSC, and HPLC. The 2D ROESY spectra did not show any dipolar proton interaction of the AMOX with cyclodextrin. The 1:1 stoichiometry of the complex was obtained by HPLC. The stability constant for AMOX with β-CD was determined to be 1,878 M−1. In the [AMOX:β-CD] complex, the phenyl group is included inside the β-CD, and the ionized carboxyl group on the penam ring forms hydrogen bonds with the secondary hydroxyl groups of another β-CD to keep the complex stable. Preparation methods allowed exactly the same complex.
引用
收藏
页码:574 / 581
页数:7
相关论文
共 117 条
  • [11] Hansmann Y(2007) isolated from healthy nasal carriers and hospital isolates J Contemp Dent Pract 8 51-9
  • [12] Kuriyama T(2008)Genetic and biochemical characterization of FUS-1 (OXA-85), a narrow-spectrum class D beta-lactamase from Aliment Pharmacol Ther 28 868-77
  • [13] Williams DW(2008) subsp. J Pharm Biomed Anal. 47 535-40
  • [14] Yanagisawa M(2007)Timing affects the clinical outcome of adjunctive systemic antibiotic therapy for generalized aggressive periodontitis Eur J Pharm Sci 30 167-74
  • [15] Iwahara K(2007)Adjunctive effects of systemic amoxicillin and metronidazole with scaling and root planing: a randomized, placebo controlled clinical trial Pharm Res 24 377-89
  • [16] Shimizu C(1998)Meta-analysis: high-dose proton pump inhibitors Chem Rev 98 2045-76
  • [17] Nakagawa K(1999). standard dose in triple therapy for J Biol Chem 274 25159-66
  • [18] Drissi M(1998) eradication J Bacteriol 180 2630-5
  • [19] Ahmed ZB(2004)Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir Thermochim Acta. 416 87-92
  • [20] Dehecq B(2003)Cyclodextrin/imatinib complexation: binding mode and charge dependent stabilities J Pharm Pharmacol 55 291-300